Anemia in a psoriatic patient treated with ixekizumab

J Dermatol. 2020 May;47(5):e209-e210. doi: 10.1111/1346-8138.15288. Epub 2020 Mar 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Chronic Disease / drug therapy
  • Dermatologic Agents / adverse effects*
  • Erythrocyte Transfusion
  • Hemoglobins / analysis
  • Humans
  • Male
  • Middle Aged
  • Psoriasis / blood
  • Psoriasis / diagnosis
  • Psoriasis / drug therapy*
  • Red-Cell Aplasia, Pure / blood
  • Red-Cell Aplasia, Pure / chemically induced*
  • Red-Cell Aplasia, Pure / diagnosis
  • Red-Cell Aplasia, Pure / therapy
  • Reticulocyte Count
  • Severity of Illness Index

Substances

  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • Hemoglobins
  • ixekizumab